These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 31177441)

  • 1. Measurement of Yersinia Translocon Pore Formation in Erythrocytes.
    Costa TRD; Francis MK; Farag SI; Edgren T; Francis MS
    Methods Mol Biol; 2019; 2010():211-229. PubMed ID: 31177441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional conservation of the effector protein translocators PopB/YopB and PopD/YopD of Pseudomonas aeruginosa and Yersinia pseudotuberculosis.
    Frithz-Lindsten E; Holmström A; Jacobsson L; Soltani M; Olsson J; Rosqvist R; Forsberg A
    Mol Microbiol; 1998 Sep; 29(5):1155-65. PubMed ID: 9767584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammasome activation in response to the Yersinia type III secretion system requires hyperinjection of translocon proteins YopB and YopD.
    Zwack EE; Snyder AG; Wynosky-Dolfi MA; Ruthel G; Philip NH; Marketon MM; Francis MS; Bliska JB; Brodsky IE
    mBio; 2015 Feb; 6(1):e02095-14. PubMed ID: 25691590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type III secretion translocon assemblies that attenuate Yersinia virulence.
    Costa TR; Amer AA; Farag SI; Wolf-Watz H; Fällman M; Fahlgren A; Edgren T; Francis MS
    Cell Microbiol; 2013 Jul; 15(7):1088-110. PubMed ID: 23279117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guanylate Binding Proteins Regulate Inflammasome Activation in Response to Hyperinjected Yersinia Translocon Components.
    Zwack EE; Feeley EM; Burton AR; Hu B; Yamamoto M; Kanneganti TD; Bliska JB; Coers J; Brodsky IE
    Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28784930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translocators YopB and YopD from Yersinia enterocolitica form a multimeric integral membrane complex in eukaryotic cell membranes.
    Montagner C; Arquint C; Cornelis GR
    J Bacteriol; 2011 Dec; 193(24):6923-8. PubMed ID: 22001511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of mammalian proteins that collaborate with type III secretion system function: involvement of a chemokine receptor in supporting translocon activity.
    Sheahan KL; Isberg RR
    mBio; 2015 Feb; 6(1):e02023-14. PubMed ID: 25691588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coiled-coils in the YopD translocator family: a predicted structure unique to the YopD N-terminus contributes to full virulence of Yersinia pseudotuberculosis.
    Costa TR; Amer AA; Fällman M; Fahlgren A; Francis MS
    Infect Genet Evol; 2012 Dec; 12(8):1729-42. PubMed ID: 22910185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LcrV is a channel size-determining component of the Yop effector translocon of Yersinia.
    Holmström A; Olsson J; Cherepanov P; Maier E; Nordfelth R; Pettersson J; Benz R; Wolf-Watz H; Forsberg A
    Mol Microbiol; 2001 Feb; 39(3):620-32. PubMed ID: 11169103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live imaging of Yersinia translocon formation and immune recognition in host cells.
    Rudolph M; Carsten A; Kulnik S; Aepfelbacher M; Wolters M
    PLoS Pathog; 2022 May; 18(5):e1010251. PubMed ID: 35604950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and Association of the Yersinia pestis Translocon Proteins, YopB and YopD, Are Facilitated by Nanolipoprotein Particles.
    Coleman MA; Cappuccio JA; Blanchette CD; Gao T; Arroyo ES; Hinz AK; Bourguet FA; Segelke B; Hoeprich PD; Huser T; Laurence TA; Motin VL; Chromy BA
    PLoS One; 2016; 11(3):e0150166. PubMed ID: 27015536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal YopB and YopD translocator secretion by Yersinia is sufficient for Yop-effector delivery into target cells.
    Edqvist PJ; Aili M; Liu J; Francis MS
    Microbes Infect; 2007 Feb; 9(2):224-33. PubMed ID: 17223369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of host membrane pore formation by the Yersinia pseudotuberculosis type III secretion system on the macrophage innate immune response.
    Kwuan L; Adams W; Auerbuch V
    Infect Immun; 2013 Mar; 81(3):905-14. PubMed ID: 23297383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The YopD translocator of Yersinia pseudotuberculosis is a multifunctional protein comprised of discrete domains.
    Olsson J; Edqvist PJ; Bröms JE; Forsberg A; Wolf-Watz H; Francis MS
    J Bacteriol; 2004 Jul; 186(13):4110-23. PubMed ID: 15205412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yersinia controls type III effector delivery into host cells by modulating Rho activity.
    Mejía E; Bliska JB; Viboud GI
    PLoS Pathog; 2008 Jan; 4(1):e3. PubMed ID: 18193942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insertion of a Yop translocation pore into the macrophage plasma membrane by Yersinia enterocolitica: requirement for translocators YopB and YopD, but not LcrG.
    Neyt C; Cornelis GR
    Mol Microbiol; 1999 Sep; 33(5):971-81. PubMed ID: 10476031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of predicted transmembrane domains for type III translocation, pore formation, and signaling by the Yersinia pseudotuberculosis YopB protein.
    Ryndak MB; Chung H; London E; Bliska JB
    Infect Immun; 2005 Apr; 73(4):2433-43. PubMed ID: 15784589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YopK of Yersinia pseudotuberculosis controls translocation of Yop effectors across the eukaryotic cell membrane.
    Holmström A; Petterson J; Rosqvist R; Håkansson S; Tafazoli F; Fällman M; Magnusson KE; Wolf-Watz H; Forsberg A
    Mol Microbiol; 1997 Apr; 24(1):73-91. PubMed ID: 9140967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yersinia pseudotuberculosis YopD mutants that genetically separate effector protein translocation from host membrane disruption.
    Adams W; Morgan J; Kwuan L; Auerbuch V
    Mol Microbiol; 2015 May; 96(4):764-78. PubMed ID: 25684661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage innate immune responses delineate between defective translocon assemblies produced by
    Farag SI; Francis MK; Gurung JM; Wai SN; Stenlund H; Francis MS; Nadeem A
    Virulence; 2023 Dec; 14(1):2249790. PubMed ID: 37621095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.